Detalles de la búsqueda
1.
Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.
J Am Soc Nephrol
; 31(11): 2725-2735, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32963090
2.
Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department.
J Emerg Med
; 61(3): 298-313, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34092446
3.
Development and validation of prognostic machine learning models for short- and long-term mortality among acutely admitted patients based on blood tests.
Sci Rep
; 14(1): 5942, 2024 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38467752
4.
Biomarkers and the post-thrombotic syndrome: A systematic review of biomarkers associated with the occurrence of the post-thrombotic syndrome after lower extremity deep venous thrombosis.
Phlebology
; 38(9): 577-598, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37620994
5.
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19.
J Am Heart Assoc
; 11(18): e025198, 2022 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35924778
6.
suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19.
Biomark Insights
; 16: 11772719211034685, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34421295
Resultados
1 -
6
de 6
1
Próxima >
>>